Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Lymphoma 51Lymphoma, Follicular 36Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 29Lymphoma, Large B-Cell, Diffuse 25Lymphoma, Mantle-Cell 23Leukemia 23Lymphoma, Large-Cell, Immunoblastic 20Hodgkin Disease 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 12Multiple Myeloma 12Neoplasms, Plasma Cell 9Leukemia, Myeloid, Accelerated Phase 9Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Congenital Abnormalities 8Waldenstrom Macroglobulinemia 7Recurrence 7Blast Crisis 7Lymphoma, T-Cell, Cutaneous 6Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Dendritic Cell Sarcoma, Interdigitating 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Peripheral Blood Stem Cell Transplantation 17fludarabine phosphate 15Cyclophosphamide 14Cyclosporine 12Whole-Body Irradiation 11Mycophenolic Acid 11Etoposide 7Tacrolimus 5Filgrastim 5Antilymphocyte Serum 5Therapeutics 4Rituximab 4Radiotherapy 4Psychiatric Rehabilitation 4Methylprednisolone 4Melphalan 4Busulfan 4Bortezomib 4Transplantation 3Thiotepa 3Prednisone 3Methotrexate 3Epoetin Alfa 3Dasatinib 3Darbepoetin alfa 3Carboplatin 3Alemtuzumab 3thymoglobulin 2nelarabine 2liposomal amphotericin B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Large Granular Lymphocytic × sargramostim × Lymphoid × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡